Francis Arickx

522 total citations
11 papers, 209 citations indexed

About

Francis Arickx is a scholar working on Economics and Econometrics, Pediatrics, Perinatology and Child Health and General Health Professions. According to data from OpenAlex, Francis Arickx has authored 11 papers receiving a total of 209 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Economics and Econometrics, 3 papers in Pediatrics, Perinatology and Child Health and 2 papers in General Health Professions. Recurrent topics in Francis Arickx's work include Health Systems, Economic Evaluations, Quality of Life (11 papers), Pharmaceutical Economics and Policy (10 papers) and Pharmaceutical studies and practices (3 papers). Francis Arickx is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (11 papers), Pharmaceutical Economics and Policy (10 papers) and Pharmaceutical studies and practices (3 papers). Francis Arickx collaborates with scholars based in Belgium, Netherlands and Italy. Francis Arickx's co-authors include Steven Simoens, Thomas Morel, P.D. Siviero, Entela Xoxi, Séverine Henrard, Gilberto Montibeller, Panos Kanavos, Aris Angelis, Mark Linch and Anna Zawada and has published in prestigious journals such as Social Science & Medicine, Bulletin of the World Health Organization and Value in Health.

In The Last Decade

Francis Arickx

10 papers receiving 202 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francis Arickx Belgium 6 160 38 22 20 17 11 209
Hanna I. Hyry United Kingdom 7 128 0.8× 43 1.1× 31 1.4× 34 1.7× 14 0.8× 8 230
Josep Torrent-Farnell Spain 6 164 1.0× 60 1.6× 37 1.7× 29 1.4× 15 0.9× 10 256
Enrico Costa Italy 8 91 0.6× 63 1.7× 39 1.8× 23 1.1× 13 0.8× 26 284
Robyn Lim Canada 6 123 0.8× 19 0.5× 12 0.5× 38 1.9× 20 1.2× 12 206
Eline Picavet Belgium 11 217 1.4× 90 2.4× 44 2.0× 17 0.8× 9 0.5× 20 299
Gigi Hirsch United States 7 135 0.8× 19 0.5× 12 0.5× 38 1.9× 27 1.6× 15 268
Nathalie Bere Netherlands 5 88 0.6× 22 0.6× 9 0.4× 10 0.5× 41 2.4× 8 158
Juan Carlos Rejón-Parrilla United Kingdom 8 102 0.6× 14 0.4× 11 0.5× 20 1.0× 56 3.3× 15 197
Marlene E. Haffner United States 9 167 1.0× 80 2.1× 85 3.9× 30 1.5× 19 1.1× 23 323
Guillaume Dedet France 7 196 1.2× 32 0.8× 5 0.2× 8 0.4× 21 1.2× 10 297

Countries citing papers authored by Francis Arickx

Since Specialization
Citations

This map shows the geographic impact of Francis Arickx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francis Arickx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francis Arickx more than expected).

Fields of papers citing papers by Francis Arickx

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francis Arickx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francis Arickx. The network helps show where Francis Arickx may publish in the future.

Co-authorship network of co-authors of Francis Arickx

This figure shows the co-authorship network connecting the top 25 collaborators of Francis Arickx. A scholar is included among the top collaborators of Francis Arickx based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francis Arickx. Francis Arickx is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Angelis, Aris, Mark Linch, Gilberto Montibeller, et al.. (2019). Multiple Criteria Decision Analysis for HTA across four EU Member States: Piloting the Advance Value Framework. Social Science & Medicine. 246. 112595–112595. 28 indexed citations
2.
Zelei, Tamás, Francis Arickx, Anna Bucsics, et al.. (2018). The European challenges of funding orphan medicinal products. Orphanet Journal of Rare Diseases. 13(1). 184–184. 31 indexed citations
3.
Arickx, Francis, et al.. (2016). Insights from 6 Years' Managed Entry Agreement Experience in Belgium. Value in Health. 19(7). A499–A499.
4.
Arickx, Francis, et al.. (2016). Success and Failure of Straightforward Versus Sophisticated Managed Entry Agreements. Value in Health. 19(7). A499–A499. 1 indexed citations
5.
Henrard, Séverine & Francis Arickx. (2016). Negotiating prices of drugs for rare diseases. Bulletin of the World Health Organization. 94(10). 779–781. 25 indexed citations
7.
Morel, Thomas, et al.. (2013). Managed Entry Agreements and Orphan Drugs: A European Comparative Study (2006-2012). Value in Health. 16(7). A391–A391. 4 indexed citations
8.
Adriaens, Carmen, et al.. (2012). Mechanism of coordinated access to orphan drugs. Orphanet Journal of Rare Diseases. 7(Suppl 2). A24–A24. 10 indexed citations
9.
Annemans, Lieven, Francis Arickx, Marc G. Bogaert, et al.. (2010). A call to make valuable innovative medicines available in the European Union. 5 indexed citations
10.
Annemans, Lieven, et al.. (2010). The increasing role of health economic evaluations in drug development. Drug Development Research. 71(8). 457–462. 4 indexed citations
11.
Arickx, Francis, et al.. (2009). PCV162 PUBLIC TENDERING FOR OFF PATENT PHARMACEUTICALS IN BELGIUM—THE SIMVASTATIN CASE. Value in Health. 12(7). A343–A343. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026